Medicare Clinical Trial Policy May Improve Outcomes Data - HHS Panelist
Executive Summary
Coverage of clinical trial costs under Medicare may lead to improved data for policy makers seeking to assess therapeutic outcomes in the elderly, Bruce Stuart, PhD, University of Maryland, suggested during the Aug. 8-9 HHS drug pricing conference in Washington, D.C.
You may also be interested in...
Medicare coverage of clinical trials
Medicare will cover routine costs of qualifying clinical trials, as well as reasonable and necessary items and services used to diagnose and treat complications arising from participation in clinical trials, effective immediately, the Health Care Financing Administration announced Sept. 19. The purpose of the trial must be the evaluation of an item or service that falls within a Medicare benefit category (1"The Pink Sheet" Aug. 21, p. 6)
Medicare coverage of clinical trials
Medicare will cover routine costs of qualifying clinical trials, as well as reasonable and necessary items and services used to diagnose and treat complications arising from participation in clinical trials, effective immediately, the Health Care Financing Administration announced Sept. 19. The purpose of the trial must be the evaluation of an item or service that falls within a Medicare benefit category (1"The Pink Sheet" Aug. 21, p. 6)
House State-Based Senior Rx Plan Includes Funds For Pharmacy Services
State governments would be required to allocate a "reasonable percentage" of federal funding for senior drug assistance programs to cover the cost of pharmacy services under Rep. Bilirakis' (R-Fla.) HR 5151.